JP2005518801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005518801A5 JP2005518801A5 JP2003572502A JP2003572502A JP2005518801A5 JP 2005518801 A5 JP2005518801 A5 JP 2005518801A5 JP 2003572502 A JP2003572502 A JP 2003572502A JP 2003572502 A JP2003572502 A JP 2003572502A JP 2005518801 A5 JP2005518801 A5 JP 2005518801A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- variant
- amino acid
- wild
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36018102P | 2002-03-01 | 2002-03-01 | |
| US40104202P | 2002-08-06 | 2002-08-06 | |
| PCT/SE2003/000331 WO2003073980A2 (en) | 2002-03-01 | 2003-02-28 | Recombinant protein c variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005518801A JP2005518801A (ja) | 2005-06-30 |
| JP2005518801A5 true JP2005518801A5 (https=) | 2006-05-18 |
Family
ID=27791634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003572502A Pending JP2005518801A (ja) | 2002-03-01 | 2003-02-28 | 組換えプロテインｃバリアント |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050176083A1 (https=) |
| EP (1) | EP1483380A2 (https=) |
| JP (1) | JP2005518801A (https=) |
| AU (1) | AU2003212739B2 (https=) |
| CA (1) | CA2477876A1 (https=) |
| WO (1) | WO2003073980A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008048646A1 (en) * | 2006-10-18 | 2008-04-24 | Socratech L.L.C. | Use of human protein c with altered glycosylation and sialic acid content as a medicament |
| US20110171200A1 (en) * | 2008-01-15 | 2011-07-14 | Walley Keith R | Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| WO2012068519A2 (en) | 2010-11-19 | 2012-05-24 | Sirius Genomics Inc. | Markers associated with response to activated protein c administration, and uses thereof |
| WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701228D0 (sv) * | 1997-04-03 | 1997-04-03 | Bjoern Dahlbaeck | Rekombinanta protein-C-och protein-S-varianter |
| US6017882A (en) * | 1997-10-23 | 2000-01-25 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
| CA2391651A1 (en) * | 1999-11-19 | 2001-05-25 | Eli Lilly And Company | Protein c derivatives |
| WO2001057193A2 (en) * | 2000-02-02 | 2001-08-09 | Eli Lilly And Company | Protein c derivatives |
-
2003
- 2003-02-28 WO PCT/SE2003/000331 patent/WO2003073980A2/en not_active Ceased
- 2003-02-28 AU AU2003212739A patent/AU2003212739B2/en not_active Ceased
- 2003-02-28 US US10/506,080 patent/US20050176083A1/en not_active Abandoned
- 2003-02-28 EP EP03708766A patent/EP1483380A2/en not_active Withdrawn
- 2003-02-28 JP JP2003572502A patent/JP2005518801A/ja active Pending
- 2003-02-28 CA CA002477876A patent/CA2477876A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9982248B2 (en) | Factor IX polypeptide mutant, its uses and method for its production | |
| US10293043B2 (en) | Methods of lowering serum cholesterol | |
| JP6861152B2 (ja) | 治療用変異体アルファ２−マクログロブリン組成物 | |
| JP5427409B2 (ja) | 自己免疫疾患及び移植片拒絶反応を治療するためのＩｄｅＳプロテイナーゼ（化膿連鎖球菌由来）の使用 | |
| Liu et al. | Mesenchymal Stem Cells Promote the Osteogenesis in Collagen‐Induced Arthritic Mice through the Inhibition of TNF‐α | |
| TWI851647B (zh) | 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體 | |
| MXPA04010061A (es) | Factor viii modificado. | |
| TWI355419B (en) | Expression system and method for producing gamma-c | |
| US20060154331A1 (en) | Erythrocyte differentiation factor, gene encoding same, and methods of use thereof | |
| WO1998044128A1 (en) | Novel human serine carboxypeptidase | |
| JP2005518801A5 (https=) | ||
| EP1860182B1 (en) | Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof | |
| JP2021530524A (ja) | 発現が増強された組換えｆｖｉｉｉ変異体をコードするウイルスベクターを使用する血友病ａの遺伝子療法 | |
| WO1996016987A1 (en) | Thrombocytotic factor | |
| JP2008502323A (ja) | コブラ毒因子様機能を有するヒト補体ｃ３誘導体 | |
| EP1598367A1 (en) | Modified coagulation factors with enhanced stability and their derivatives | |
| US6835381B1 (en) | Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor | |
| CN119101140B (zh) | 一种促骨形成多肽及其应用 | |
| TW459044B (en) | Protein MP-121 of the TGF-β-like family | |
| JP2004256436A (ja) | アグリカナーゼ−１阻害剤 | |
| WO2026082097A1 (zh) | 多肽、rna分子及其医药用途 | |
| KR20250027325A (ko) | 병인성 비멘틴과 감염병 동반 악화 강직성척추염 질환 약물개발 모니터링 플랫폼 | |
| WO2022264040A1 (en) | Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression | |
| EP1192181B1 (en) | Modulation of angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor for the treatment of tumor | |
| JP2023506171A (ja) | 発現が上昇した組換えｆｖｉｉｉバリアントをコードするウイルスベクターを使用する、血友病ａの遺伝子療法 |